Published in J Cardiovasc Magn Reson on January 01, 2000
Left ventricular regional wall curvedness and wall stress in patients with ischemic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol (2009) 1.13
Infarct zone viability influences ventricular remodelling after late recanalisation of an occluded infarct related artery. Heart (2005) 1.04
Right ventricular regional wall curvedness and area strain in patients with repaired tetralogy of Fallot. Am J Physiol Heart Circ Physiol (2011) 1.02
Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study. Heart (2004) 0.88
Novel techniques for assessment of left ventricular systolic function. Heart Fail Rev (2011) 0.82
Influence of the short-axis cine acquisition protocol on the cardiac function evaluation: A reproducibility study. Eur J Radiol Open (2016) 0.81
Multimodality imaging in apical hypertrophic cardiomyopathy. World J Cardiol (2014) 0.81
Contrast-enhanced adenosine-stress magnetic resonance imaging--feasibility and practicability of a protocol for detection or exclusion of ischemic heart disease in an outpatient setting. Clin Res Cardiol (2006) 0.81
Comparison of echocardiographic (US) volumetry with cardiac magnetic resonance (CMR) imaging in transfusion dependent thalassemia major (TM). Cardiovasc Ultrasound (2007) 0.79
Hypertrophic cardiomyopathy and ultra-endurance running - two incompatible entities? J Cardiovasc Magn Reson (2011) 0.79
Cardiovascular magnetic resonance in pregnancy: insights from the cardiac hemodynamic imaging and remodeling in pregnancy (CHIRP) study. J Cardiovasc Magn Reson (2014) 0.78
Automatic vs semi-automatic global cardiac function assessment using 64-row CT. Br J Radiol (2011) 0.76
Significance of deep T-wave inversions in asymptomatic athletes with normal cardiovascular examinations: practical solutions for managing the diagnostic conundrum. Br J Sports Med (2012) 0.76
Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study. Heart Int (2006) 0.75
Non-invasive cardiac evaluation in heart failure patients using magnetic resonance imaging: a feasibility study. Heart Fail Rev (2005) 0.75
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J (2001) 8.90
Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med (2001) 7.05
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet (1997) 6.48
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J (2000) 4.99
Incidence and aetiology of heart failure; a population-based study. Eur Heart J (1999) 4.56
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation (2003) 4.48
Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2006) 4.27
Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J (2001) 3.49
Wasting as independent risk factor for mortality in chronic heart failure. Lancet (1997) 3.37
The endotoxin-lipoprotein hypothesis. Lancet (2000) 3.03
Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet (1999) 3.01
A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation (2007) 2.93
Survival of patients with a new diagnosis of heart failure: a population based study. Heart (2000) 2.86
Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2000) 2.85
Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation (2009) 2.85
Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J (1998) 2.73
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation (1997) 2.69
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet (2003) 2.64
Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax (2001) 2.50
Enzyme-linked immunosorbent assay (ELISA) using antibody class capture for the detection of antitoxoplasma IgM. J Clin Pathol (1982) 2.47
Knowledge and communication difficulties for patients with chronic heart failure: qualitative study. BMJ (2000) 2.47
Screening for hypertrophic cardiomyopathy. BMJ (1993) 2.31
Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1997) 2.27
Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation (1998) 2.26
Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart (2004) 2.22
Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol (1997) 2.19
Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation (2000) 2.18
Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol (1997) 2.08
Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J (2000) 2.06
Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol (1997) 2.05
Second trimester ambulatory blood pressure in nulliparous pregnancy: a useful screening test for pre-eclampsia? Br J Obstet Gynaecol (1993) 2.04
Severity of heart failure and dosage of angiotensin converting enzyme inhibitors. BMJ (1995) 1.99
Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J (1998) 1.97
Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson (2006) 1.97
Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation (1996) 1.88
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J (1997) 1.80
Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. Am J Cardiol (2001) 1.79
Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload. Eur Heart J (2003) 1.79
Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol (1996) 1.76
Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation (2001) 1.75
Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation (2000) 1.72
Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol (2001) 1.71
Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Eur Heart J (2000) 1.66
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol (1997) 1.63
Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br J Cancer (2002) 1.62
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J (1997) 1.55
Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training. Eur Heart J (1995) 1.50
Images in cardiovascular medicine. Isolated noncompaction of the myocardium: a rarity or missed diagnosis? Circulation (2002) 1.48
Heart Failure 99 -- the MOXCON story. Int J Cardiol (1999) 1.48
Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. Eur Heart J (2001) 1.47
The impact of cachexia on cardiorespiratory reflex control in chronic heart failure. Eur Heart J (1999) 1.44
Angiotensin-converting enzyme inhibition and physical training in heart failure. J Intern Med (1991) 1.42
Behavioral characterization of neuropeptide Y knockout mice. Brain Res (2000) 1.40
Validation of ambulatory monitors in special populations. Am J Hypertens (1992) 1.40
Non-invasive assessment of vascular function; paradoxical vascular response to intravenous glucose in coronary heart disease. Eur Heart J (2000) 1.39
Angiotensin receptor blockers -- finally the evidence is coming in: IDNT and RENAAL. Int J Cardiol (2001) 1.38
Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation (1997) 1.38
Echo-planar magnetic resonance myocardial perfusion imaging: parametric map analysis and comparison with thallium SPECT. J Magn Reson Imaging (2001) 1.37
Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J (2001) 1.35
Risk stratification in chronic heart failure. Eur Heart J (1998) 1.33
Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation (2001) 1.33
Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol (1999) 1.32
Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol (1997) 1.29
Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma. Clin Infect Dis (1993) 1.28
Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol (1996) 1.27
Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest (1999) 1.26
Coronary artery imaging in grown up congenital heart disease: complementary role of magnetic resonance and x-ray coronary angiography. Circulation (2000) 1.26
Lisinopril and enalapril in hypertension: a comparative study using ambulatory monitoring. J Hum Hypertens (1990) 1.26
Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: clinical implications and role of augmented peripheral chemosensitivity. Circulation (1999) 1.25
Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart (2005) 1.24
Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol (1993) 1.24
A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community. Eur J Heart Fail (2000) 1.24
MR navigator-echo monitoring of temporal changes in diaphragm position: implications for MR coronary angiography. J Magn Reson Imaging (1997) 1.24
Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis (2004) 1.21
Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J (1999) 1.20
Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol (1998) 1.19
Domperidone and levodopa in Parkinson's disease. Br J Clin Pharmacol (1984) 1.19
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation (2001) 1.18
A neural link to explain the "muscle hypothesis" of exercise intolerance in chronic heart failure. Am Heart J (1999) 1.17
False positive results with heated sera in Toxoplasma ELISA for IgG antibody. J Clin Pathol (1987) 1.15
Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol (1997) 1.15
Predictors of exercise capacity in chronic heart failure. Eur Heart J (1994) 1.14
Dissociable long-term cognitive deficits after frontal versus sensorimotor cortical contusions. J Neurotrauma (1998) 1.14
Persistent peripheral vasodilation and sympathetic activity in hypotension after maximal exercise. J Appl Physiol (1985) (1993) 1.12
The relationship between plasma catecholamines and severity of injury in man. J Trauma (1984) 1.11
Muscle metaboreceptors in hemodynamic, autonomic, and ventilatory responses to exercise in men. Am J Physiol (1995) 1.11
Heart rhythms, ventricular arrhythmias, and death in chronic heart failure. J Card Fail (1996) 1.11
Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. Eur Heart J (1997) 1.10
Adaptive servo-ventilation and deadspace: effects on central sleep apnoea. J Sleep Res (2006) 1.10
Explaining fatigue in congestive heart failure. Annu Rev Med (1996) 1.09
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol (2001) 1.09
Cardiovascular magnetic resonance imaging for non-invasive assessment of vascular function: validation against ultrasound. J Cardiovasc Magn Reson (2006) 1.08
Muscle fatigue and dyspnoea in chronic heart failure: two sides of the same coin? Eur Heart J (1995) 1.08
Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy. Heart (2004) 1.08